French authorities will present a first draft of the long-awaited pricing and reimbursement decree for medical cannabis on February 18,
Augur Associates and Newsweed, two organisations at the forefront of the ongoing developments in the region, believe that the incoming system not only sidesteps many of the issues other countries have faced in the implementation phase, but that it could reestablish the country’s standing as a model of inspiration for neighbouring states and prospective forthcoming EU supra-regulation.
We won’t spam you
